Clinical Trial Update: Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating asciminib as initial therapy for adults with chronic-phase chronic myeloid leukemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Asciminib (asciminib)

Snippet

Sponsor: Augusta University | Conditions: Chronic Myeloid Leukemia, Chronic Phase, Adult CML | Phase 2 | Status: RECRUITING